American Society of Hirudotherapy

Distal digit replantation: challenges and strategies to improve outcomes

Review published in Semin Plast Surg (2025)

Last Updated: November 1, 2026ASH Editorial · based on the books
Research article — evidence review: Off-label use means application outside the FDA-cleared indication. Clinical evidence (RCTs or systematic reviews) supports this use, but the FDA has not cleared it.Article reference: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.
Evidence: Narrative reviewClinical LiteratureHsu et al. · Seminars in plastic surgery, 2025

Abstract

Digit replantation has undergone significant advancements since the 1960s. Despite progress, distal digit replantation remains one of the most challenging microsurgical procedures due to technical and clinical complexities. This review examines current challenges, strategic solutions in distal digit replantation, grounded in clinical experience and literature review. Key obstacles include managing minute vessel structures, venous congestion, and the critical condition of no available vessels for revascularization. Advances in surgical techniques, including preosteosynthesis vein grafting, intravascular stent, solitary central pulp artery bifurcation division, subdermal pocketing method, and postoperative management, have enhanced outcomes.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleReview

Summary

Review of distal digit replantation challenges highlights obstacles including minute vessels, venous congestion, and lack of revascularization options, and discusses advances such as preosteosynthesis vein grafting, intravascular stents, and subdermal pocketing techniques to improve outcomes.

Why This Matters for Hirudotherapy

This review examines challenges and strategic solutions in distal digit replantation, identifying venous congestion and scenarios with no available vessels for revascularization as key clinical obstacles. The relevance to hirudotherapy is strong and well-established: medicinal leech therapy is a recognized adjunct for managing venous congestion following digit replantation, where leech-mediated bloodletting and hirudin-driven anticoagulation help sustain tissue viability when venous outflow is inadequate. The abstract's discussion of postoperative management further highlights the clinical space where leech therapy is typically deployed. An honest caveat: this is a narrative review centered on surgical techniques rather than a study evaluating leech therapy itself, so it provides no outcome data specific to hirudotherapy.

Citation

Reference (Vancouver style)

Hsu CC, Lu YJ. Distal digit replantation: challenges and strategies to improve outcomes. Semin Plast Surg. 2025;39(3):121-128. doi:10.1055/s-0045-1809651. PMID: 40786021

Bibliographic details (authors, volume, pages, DOI) are taken from the PubMed record.

Added to ASH library: May 27, 2026 · Site last updated: November 1, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.